MARKET

ELAT

Elanco Animal Health Inc
ELAT
NYSE
Delisted
P/E
P/S
P/B
MARKET CAP
-39.1205
2.180
1.499
234,520,000.00
BUZZ-Animal health companies rise after screwworm case in Texas
Reuters · 06/04 14:07
ELANCO ANIMAL HEALTH - OFFERS TREATMENT OPTIONS FOR LIVESTOCK AND PETS AGAINST NEW WORLD SCREWWORM
Reuters · 06/04 10:26
Elanco survey shows US pet owners keep pet health spending steady despite rising costs
PUBT · 06/03 11:26
Elanco Animal Health shareholders elect directors at annual meeting
PUBT · 05/27 21:01
Elanco EVP Rajeev Modi acquires 4,911 common shares worth $99,923.85
PUBT · 05/19 20:40
Elanco CEO Jeffrey Simmons acquires 4,971 shares for $99,874.54
PUBT · 05/19 20:39
ELANCO LAUNCHES BEFRENA™ (TIRNOVETMAB), NEW ANTI-IL-31 MONOCLONAL ANTIBODY, A BREAKTHROUGH ADDITION TO THE $1.3 BILLION U.S. CANINE DERMATOLOGY MARKET
Reuters · 05/18 11:27
BUZZ-U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
Reuters · 05/06 17:51
More

Webull offers Elanco Animal Health Inc stock information, including NYSE: ELAT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELAT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELAT stock methods without spending real money on the virtual paper trading platform.